Strahlentherapie beim metastasierten Nierenzellkarzinom

Translated title of the contribution: Radiotherapy of metastasized renal cell carcinoma

B. van Oorschot*, B. Polat, D. Rades

*Corresponding author for this work


Background: Nearly 50 % of all patients suffering from renal cell cancer develop metastases during the course of the disease.

Objective: The aim of this article is to describe the options for radiotherapy of metastatic renal cell carcinoma.

Material and methods: A systematic search of the literature for articles on radiotherapy of metastatic renal cell carcinoma was carried out.

Results: A new treatment option for long-term local control especially for oligometastatic patients is high-dose stereotactic radiotherapy. Local control rates are around 80 % or higher; however, moderately hypofractionated radiotherapy remains the treatment of choice for symptomatic patients with multiple brain metastases and for patients in a poor general condition with symptomatic bone or other extracranial metastases. Alleviation of symptoms is achieved in 60–80 %.

Translated title of the contributionRadiotherapy of metastasized renal cell carcinoma
Original languageGerman
Issue number1
Pages (from-to)50-54
Number of pages5
Publication statusPublished - 01.2014


Dive into the research topics of 'Radiotherapy of metastasized renal cell carcinoma'. Together they form a unique fingerprint.

Cite this